Imunon Statistics
Share Statistics
Imunon has 17.54M
shares outstanding. The number of shares has increased by 55.52%
in one year.
| Shares Outstanding | 17.54M |
| Shares Change (YoY) | 55.52% |
| Shares Change (QoQ) | 0.83% |
| Owned by Institutions (%) | 2.94% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,376 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.15M, so 6.54% of the outstanding
shares have been sold short.
| Short Interest | 1.15M |
| Short % of Shares Out | 6.54% |
| Short % of Float | 6.61% |
| Short Ratio (days to cover) | 2.68 |
Valuation Ratios
The PE ratio is -0.74 and the forward
PE ratio is -1.83.
Imunon's PEG ratio is
0.01.
| PE Ratio | -0.74 |
| Forward PE | -1.83 |
| PS Ratio | 0 |
| Forward PS | 0.3 |
| PB Ratio | 3.25 |
| P/FCF Ratio | -0.73 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Imunon.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67,
with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.67 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-744,809.68 |
| Employee Count | 25 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 41.1% in the
last 52 weeks. The beta is 1.75, so Imunon's
price volatility has been higher than the market average.
| Beta | 1.75 |
| 52-Week Price Change | 41.1% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 67.8 |
| Average Volume (20 Days) | 9,313,329 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.13M |
| Net Income | -18.62M |
| EBITDA | -17.98M |
| EBIT | -18.7M |
| Earnings Per Share (EPS) | -1.72 |
Full Income StatementBalance Sheet
The company has 5.87M in cash and 1.14M in
debt, giving a net cash position of 4.73M.
| Cash & Cash Equivalents | 5.87M |
| Total Debt | 1.14M |
| Net Cash | 4.73M |
| Retained Earnings | -406.8M |
| Total Assets | 6.86M |
| Working Capital | -704.93K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -18.85M
and capital expenditures -29.54K, giving a free cash flow of -18.88M.
| Operating Cash Flow | -18.85M |
| Capital Expenditures | -29.54K |
| Free Cash Flow | -18.88M |
| FCF Per Share | -1.3 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
